Government news, all in one place
Government news, all in one place
The Medicines and Healthcare products Regulatory Agency (MHRA) is a UK government agency responsible for ensuring that medicines, medical devices, and blood components for transfusion meet applicable standards of safety, quality, and efficacy.
Based on publicly published press releases (last 12 months)
820 articles
Showing 1-30
Wednesday, 08 April 2026
The MHRA continues to be at the forefront of innovation and secures multi-year funding to expand its pioneering AI Airlock programme....
Tuesday, 07 April 2026
The MHRA-led Access Consortium 2026 action plan will deepen collaboration, streamline work sharing, and speed up access to safe, high-quality medicine...
Thursday, 02 April 2026
The Medicines and Healthcare products Regulatory Agency and the US Food and Drug Administration are strengthening cooperation on medical device regula...
Thursday, 02 April 2026
As with any medicine, the MHRA will keep the safety and effectiveness of sevabertinib under close review. ...
Wednesday, 25 March 2026
Emerging technologies like AI and advanced therapies are transforming healthcare, and through international collaboration with partners such as Singap...
Tuesday, 24 March 2026
As with all clinical trials, the MHRA’s top priority is the safety and wellbeing of the trial participants....
Tuesday, 24 March 2026
Medicines and Healthcare products Regulatory Agency (MHRA) takes decisive action to phase out animal testing by helping developers to make greater use...
Monday, 23 March 2026
As a precautionary measure, Mölnlycke Health Care is recalling three batches of Hibiwash, an antimicrobial wash, due to microbial contamination at the...
Tuesday, 17 March 2026
New pathway set to synchronise licensing and value assessment decisions...
Thursday, 12 March 2026
Expanding medicine reclassification could improve access to treatments, empower self-care, and reduce pressure on NHS services....
Thursday, 12 March 2026
As with any medicine, the MHRA will keep the safety and effectiveness of deuruxolitinib under close review....
Tuesday, 10 March 2026
New analysis shows Clinical Practice Research Datalink has supported groundbreaking medical research across 29 countries with close to 3,800 published...
Friday, 06 March 2026
The MHRA?has advised pharmacy and healthcare professionals to return all remaining stock to their suppliers...
Tuesday, 03 March 2026
A man who unlawfully supplied Class B and Class C controlled drugs and a range of unauthorised medicines has been sentenced at Stoke-on-Trent Crown Co...
Friday, 27 February 2026
As with all clinical trials, the MHRA’s top priority is the safety and wellbeing of the trial participants....
Wednesday, 25 February 2026
The MHRA invited the next generation of doctors to explore how genetics could improve prescribing and patient safety in the UK....
Wednesday, 25 February 2026
Officers from the MHRA's Criminal Enforcement Unit (CEU) have raided two separate premises as part of an ongoing investigation into an organised crimi...
Tuesday, 24 February 2026
Fake medicines are illegally produced products that may contain incorrect ingredients, no active ingredients, or harmful substances. ...
Tuesday, 24 February 2026
As with any medicine, the MHRA will keep the safety and effectiveness of imlunestrant tosylate under close review....
Tuesday, 24 February 2026
By Richard Stubbs...
Monday, 23 February 2026
As with any medicine, the MHRA will keep the safety and effectiveness of brensocatib under close review....
Friday, 20 February 2026
With all complex clinical trials, MHRA’s top priority is the safety and wellbeing of the trial participants ...
Thursday, 19 February 2026
Zanidatamab is used when the cancer cannot be removed by surgery and has spread to nearby tissues or other parts of the body. ...
Thursday, 19 February 2026
Patients benefit from earlier access to technologies that could improve or save lives, as the MHRA approved 17 per cent more clinical investigations i...
Monday, 16 February 2026
MHRA launches a consultation on indefinite recognition of CE-marked medical devices ...
Friday, 13 February 2026
People are urged to avoid risky online buys and protect their health, as the MHRA seizes over 4.4 million doses of unlicensed erectile dysfunction med...
Wednesday, 11 February 2026
The vaccine should not be used in people aged 60 or over, and in individuals of any age who have high blood pressure, heart disease, diabetes, or chro...
Thursday, 05 February 2026
MHRA updates product information regarding the very rare risk of non-arteritic anterior ischemic optic neuropathy (NAION) in patients taking semagluti...
Monday, 02 February 2026
By Julia Vitarello ...
Thursday, 29 January 2026
Updated product information for healthcare professionals and patients regarding the small risk of severe acute pancreatitis in patients taking GLP-1s...
Environment Agency Essex skip-hire boss and firm plead guilty to waste crime charges
Planning Inspectorate Springwell Solar Farm development consent decision announced
Disclosure and Barring Service DBS launches its 2026-2027 business plan
Legal Aid Agency Civil Eligibility Keycard 2026
Homes England Homes England agrees multi-million-pound debt facility with Richborough